Literature DB >> 9351737

Cardiovascular complications of malignant carcinoid disease.

A S Anderson1, D Krauss, R Lang.   

Abstract

Carcinoid tumors are endocrinologic malignancies often associated with a characteristic syndrome-the malignant carcinoid syndrome. Cardiovascular manifestations of this rare illness result from unique pathophysiologic characteristics, are associated with poor prognosis, and are difficult to treat medically. The hemodynamic consequences of this disease present unique management problems perioperatively. New pharmacologic and surgical therapies for malignant carcinoids have improved quality of life for patients to the extent that carcinoid heart disease now has more impact on morbidity and mortality rates. Cardiologists may be called on to diagnose and treat this rare cardiac disease. We review, for consulting cardiologists, the pathophysiologic characteristics, cardiovascular manifestations, and management of this disease.

Entities:  

Mesh:

Year:  1997        PMID: 9351737     DOI: 10.1016/s0002-8703(97)70053-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Carcinoid Heart Disease.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

2.  A most unusual acute coronary syndrome.

Authors:  C Bourgault; Sebastien Bergeron; Peter Bogaty; Paul Poirier
Journal:  Can J Cardiol       Date:  2006-04       Impact factor: 5.223

3.  Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine.

Authors:  Gianluca Masi; Lorenzo Fornaro; Samanta Cupini; Fotios Loupakis; Enrico Vasile; Giacomo G Baldi; Irene Stasi; Lisa Salvatore; Alfredo Falcone
Journal:  Nat Rev Clin Oncol       Date:  2009-11       Impact factor: 66.675

4.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 5.  Advanced typical and atypical carcinoid tumours of the lung: management recommendations.

Authors:  B Melosky
Journal:  Curr Oncol       Date:  2018-06-13       Impact factor: 3.677

6.  Endocrine Heart Disease.

Authors:  Deepak R. Talreja; Gregory W. Barsness
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

7.  An unusual presentation of "silent" disseminated pancreatic neuroendocrine tumor.

Authors:  Dragomir Marisavljevic; Natasa Petrovic; Nikola Milinic; Vesna Cemerikic; Miodrag Krstic; Olivera Markovic; Dragoljub Bilanovic
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.

Authors:  Walter Noordzij; André P van Beek; René A Tio; Anouk N van der Horst-Schrivers; Elisabeth G de Vries; Bram van Ginkel; Annemiek M Walenkamp; Andor W Glaudemans; Riemer H Slart; Rudi A Dierckx
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

9.  Fatal Systemic Vasoconstriction in a Case of Metastatic Small-Intestinal NET.

Authors:  Jochen Stenzel; Sebastian Noe; Konstantin Holzapfel; Franziska Erlmeier; Florian Eyer
Journal:  Case Rep Gastrointest Med       Date:  2017-07-18

10.  Tricuspid valve regurgitation as a presenting symptom of metastasized carcinoid tumor.

Authors:  Anton F Engelsman; Peter van Duijvendijk; Bjorn E Groenemeijer; Edwin van der Zaag; Peter E Spronk; Alex Katinakis
Journal:  Case Rep Gastroenterol       Date:  2012-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.